Hämäläinen Sari, Juutilainen Auni, Matinlauri Irma, Kuittinen Taru, Ruokonen Esko, Koivula Irma, Jantunen Esa
Department of Medicine, Kuopio University Hospital, P.O. B 1777, Kuopio 70211, Finland.
Eur J Haematol. 2009 Sep;83(3):251-7. doi: 10.1111/j.1600-0609.2009.01260.x. Epub 2009 Mar 19.
Vascular endothelial growth factor (VEGF) is considered to be of importance in patients with sepsis. No data are available on VEGF kinetics in haematological patients with neutropenic fever.
Forty-two haematological patients were included into this prospective study. Median age was 57 yr (range 18-70). Fifteen patients received therapy for acute myeloid leukaemia and 27 patients received autologous stem cell transplantation for haematological malignancy. Laboratory samples for the determination of C-reactive protein (CRP) and VEGF were collected at the start of fever (d0) and then daily.
The median serum VEGF concentrations were low in all study patients. In patients with severe sepsis (n = 5) the median VEGF on d0 was higher than in septic patients without signs of hypoperfusion or hypotension (n = 37) (77 pg/mL vs. 52 pg/mL, P = 0.061). Also on d1 the median VEGF concentration was higher in patients with severe sepsis (82 pg/mL vs. 56 pg/mL, P = 0.048). There were no statistically significant differences in CRP values on any day during the study period between patients with severe sepsis and those without. Time from d0 to the peak VEGF concentration (mean 1.02, SE 0.18 d) was shorter than that to the peak CRP concentration (mean 1.93, SE 0.15 d) (P = 0.002).
Compared to CRP, serum VEGF was a more rapid indicator for sepsis in our haematological patients with neutropenic fever. Those with severe sepsis had higher VEGF concentrations than those without on d0 and d1 after the onset of fever. Further studies on VEGF are warranted in haematological patients.
血管内皮生长因子(VEGF)被认为在脓毒症患者中具有重要意义。目前尚无关于中性粒细胞减少性发热血液病患者VEGF动力学的数据。
42例血液病患者纳入本前瞻性研究。中位年龄为57岁(范围18 - 70岁)。15例患者接受急性髓系白血病治疗,27例患者接受血液系统恶性肿瘤自体干细胞移植。在发热开始时(第0天)采集用于测定C反应蛋白(CRP)和VEGF的实验室样本,随后每天采集。
所有研究患者的血清VEGF中位浓度均较低。在严重脓毒症患者(n = 5)中,第0天的VEGF中位值高于无低灌注或低血压体征的脓毒症患者(n = 37)(77 pg/mL对52 pg/mL,P = 0.061)。同样在第1天,严重脓毒症患者的VEGF中位浓度也较高(82 pg/mL对56 pg/mL,P = 0.048)。在研究期间的任何一天,严重脓毒症患者与无严重脓毒症患者的CRP值均无统计学显著差异。从第0天到VEGF浓度峰值的时间(平均1.02,标准误0.18天)短于到CRP浓度峰值的时间(平均1.93,标准误0.15天)(P = 0.002)。
在我们的中性粒细胞减少性发热血液病患者中,与CRP相比,血清VEGF是脓毒症更快速的指标。发热后第0天和第1天,严重脓毒症患者的VEGF浓度高于无严重脓毒症患者。血液病患者中对VEGF的进一步研究是必要的。